Department of Pathology
  Brigham and Women's Hospital
  A teaching Affliate of Harvard Medical School
Login Skip Navigation Links
  Skip Navigation Links
HomeExpand Home





Announcement

Submit new announcement
LAb
Thorn Building Room 603
20 Shattuck Street
Boston,MA 02115
Email1:
Office
Thorn Building 6th floor
Room 612B
Boston,MA 02115
Email1: jkutok@partners.org
Education and Training:

Medical School 1988 - 1995 : State University of New York, Stony Brook School of Medicine And Biomedical Sciences M.D.
Graduate School 1988 - 1995 : State University of New York, Stony Brook School of Medicine and biomedical Sciences. Ph.D.
Residency 1995 - 1997 : Brigham and Women's Hospital
Fellowship 1997 - 1998 : Brigham and Women's Hospital

Clinical Specialties:
  • Hematopathology
  • Molecular Diagnostics
Research Interests:
  • Leukemia
  • Lymphoma
  • Oncogenesis
  • Chromosomal translocation
  • Receptor
  • Gene expression profiling
  • Mouse models
  • Hematopoiesis
  • Myeloproliferative disorder
  • Marker identification
Publication:
  1. Rodig SJ, Abramson JS, Pinkus GS, Treon SP, Dorfman DM, Dong HY, Shipp MA, Kutok JL. Heterogeneous CD52 expression among hematologic neoplasms: implications for the use of alemtuzumab (CAMPATH-1H).Clin Cancer Res. 2006 1;12(23):7174-9
  2. Rodig SJ, Savage KJ, LaCasce AS, Weng AP, Harris NL, Shipp MA, Hsi ED, Gascoyne RD, Kutok JL. Expression of TRAF1 and Nuclear c-Rel Distinguishes Primary Mediastinal Large Cell Lymphoma from Other Types of Diffuse Large B Cell Lymphoma. Am J Surg Path. 2007 Jan;31(1):106-12.
  3. Thai TH, Calado DP, Casola S, Ansel KM, Xiao C, Xue Y, Murphy A, Frendewey D, Valenzuela D, Kutok JL, Schmidt-Supprian M, Rajewsky N, Yancopoulos G, Rao A, Rajewsky K. Regulation of the germinal center response by microRNA-155. Science. 2007 Apr 27;316(5824):604-8.
  4. Kutok JL and Wang F. EBV Spectrum of Disease. Annual Review of Pathology: Mechanisms of Disease 2006, Vol. 1: Page 375 - 404. A. Abbas, J Downing, V., Kumar eds.
  5. Kutok JL. Tumors of the Hemopoietic System. In: Fletcher CDM, ed. Diagnostic Histopathology of Tumors. Churchill Livingstone 3rd edition 2007
  6. Rodig SJ, Ouyang J, Juszczynski P, Currie T, Law K, Neuberg DS, Rabinovich GA, Shipp MA, Kutok JL. AP1-dependent Galectin-1 Expression Delineates Classical Hodgkin and Anaplastic Large Cell Lymphomas from Other Lymphoid Malignancies with Shared Molecular Features. Clin Cancer Res. 2008 Jun 1;14(11):3338-44.
  7. Xiao C, Srinivasan L, Calado DP, Patterson HC, Zhang B, Wang J, Henderson JM, Kutok JL, Rajewsky K.Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes. Nat Immunol. 2008 Apr;9(4):405-14. Epub 2008 Mar 9.
  8. Juszczynski P, Ouyang J, Monti S, Rodig SJ, Takeyama K, Abramson J, Chen W, Kutok JL, Rabinovich GA, and Shipp MA. The AP1-dependent secretion of galectin-1 by Reed–Sternberg cells fosters immune privilege in classical Hodgkin lymphoma. Proc Natl Acad Sci U S A. 2007 August 7; 104(32): 13134–13139.
  9. Aster J and Kutok J. Complexity made simple in Diffuse large B cell lymphoma. Clin Cancer Res. 2009 15(17):5291-3.
  10. Kutok JL, Yang X, Folkerth R, Adra CN. Characterization of the expression of HTm4 (MS4A3), a cell cycle regulator, in human peripheral blood cells and normal and malignant tissues. J Cell Mol Med. 2009 Oct 10. [Epub ahead of print]
  11. Gaulard P, Pileri S, Stein H, Harris NL, Jaffe ES, Kovrigina A, Kutok JL, Moller P. Primary mediastinal (thymic) large B-cell lymphoma . In WHO Classification Of Tumors: Tumours Of Hematopoietic And Lymphoid Tissues. 2nd edition. Lyon, France. IARC 2008.
  12. Srinivasan L, Sasaki Y, Calado DP, Zhang B, Paik JH, DePinho RA, Kutok JL, Kearney JF, Otipoby KL, Rajewsky K. PI3 kinase signals BCR-dependent mature B cell survival. Cell. 2009 Oct 30;139(3):573-86.
  13. Juszczynski, P, Rodig SJ, Takeyama K, Ouyang J, Mlynarski W, Mycko K, Szczepanski, T, Gaworczyk, A, Krivtsov, A, Faber, J, Sinha, AU, Rabinovich, GA, Armstrong, SA,. Kutok, JL*, Shipp, MA*. Selective Expression of the Immunoregulatory Lectin, Galectin-1, in B Lymphoblastic Leukemias with MLL Rearrangements. Clin Cancer Res. * corresponding authors. Clin Cancer Res. 2010 1;16(7):2122-30
  14. Green MR, Monti S, Rodig SJ, Juszczynski P, Currie T, O'Donnell E, Chapuy B, Takeyama K, Neuberg D, Golub TR, Kutok JL, Shipp MA. Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma. Blood. 2010 Jul 13. [Epub ahead of print]
<June 2018>
SuMoTuWeThFrSa
272829303112
3456789
10111213141516
17181920212223
24252627282930
1234567


<Monday, June 18, 2018>
8:00 AM

Cotran Conference Center
8:00 AM

Autopsy suite
1:00 PM
Dr. Reiko Nishihara, PhD
Cotran Conference Center
Copyright 2008 - 2018, BWH Pathology, All rights reserved.